Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-12-25

Clinical Trial Update: Ritalin, Memory and Attention in MCI: a Behaviour-EEG Study [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study evaluating the effects of methylphenidate (Ritalin) on memory and attention in people with Mild Cognitive I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ritalin (methylphenidate)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Mild Cognitive Impairment | Phase 4 | Status: UNKNOWN